Dutch biotech sector feel benefits of EMA move, says industr...

The Netherlands’ biotech sector has already seen an upswing following the relocation of the European Medicines Agency (EMA) to Amsterdam following Brexit, according to an influential figure

EMA proposes 10 recommendations to unlock potential of big d...

European regulators have proposed ten recommendations that aim to unlock the potential of big data for public health in the EU.

EMA counts the cost of Brexit in lost staff and narrower wor...

Merck’s last-resort antibiotic Recarbrio nears EU approval

EMA resolves dispute over pricey Canary Wharf tenancy

Alexion’s Soliris follow-up Ultomiris snares EU approval